Literature DB >> 17069755

A ubiquitin E3 ligase Efp is up-regulated by interferons and conjugated with ISG15.

Norie Nakasato1, Kazuhiro Ikeda, Tomohiko Urano, Kuniko Horie-Inoue, Satoru Takeda, Satoshi Inoue.   

Abstract

Interferon (IFN) regulates various target genes that mediate important roles in immune responses such as antiviral state. Protein ISG15-conjugation (ISGylation) is implicated in the IFN-induced antiviral response. Here we demonstrate that Efp mRNA as well as protein expression could be up-regulated by Type I IFN in HeLa cells and HepG2 cells. Luciferase assay reveals that the first intron of Efp gene contains a functional interferon-stimulated response element (ISRE) and electrophoretic mobility shift assay shows that the ISRE binds to signal transducer and activator of transcription 1 (STAT1). Chromatin immunoprecipitation assays have shown that the ISRE recruits STAT1 in vivo IFN-dependently. Moreover, we demonstrate that Efp protein could be conjugated with not only ubiquitin but also ISG15. These data suggest that Efp is an IFN-responsive gene that potentially mediates IFN actions, involved in ISGylation and ubiquitination of proteins including Efp itself.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17069755     DOI: 10.1016/j.bbrc.2006.10.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.

Authors:  Weiguo Zou; Ji Wang; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2007-01-08       Impact factor: 3.575

Review 2.  Viral defense, carcinogenesis and ISG15: novel roles for an old ISG.

Authors:  Ian F Pitha-Rowe; Paula M Pitha
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-03       Impact factor: 7.638

Review 3.  Emerging roles for immunomodulatory functions of free ISG15.

Authors:  Jessica A Campbell; Deborah J Lenschow
Journal:  J Interferon Cytokine Res       Date:  2013-09-06       Impact factor: 2.607

4.  Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells.

Authors:  Liang Qiao; Hannah Phipps-Yonas; Boris Hartmann; Thomas M Moran; Stuart C Sealfon; Fernand Hayot
Journal:  Biophys J       Date:  2010-02-17       Impact factor: 4.033

5.  TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.

Authors:  Ken-Ichi Takayama; Takashi Suzuki; Tomoaki Tanaka; Tetsuya Fujimura; Satoru Takahashi; Tomohiko Urano; Kazuhiro Ikeda; Satoshi Inoue
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

6.  IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells.

Authors:  Scott A Gerber; Jordan S Pober
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 7.  TRIM family proteins and their emerging roles in innate immunity.

Authors:  Keiko Ozato; Dong-Mi Shin; Tsung-Hsien Chang; Herbert C Morse
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

8.  RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation.

Authors:  Song-Fang Wu; Li Xia; Xiao-Dong Shi; Yu-Jun Dai; Wei-Na Zhang; Jun-Mei Zhao; Wu Zhang; Xiang-Qin Weng; Jing Lu; Huang-Ying Le; Sheng-Ce Tao; Jiang Zhu; Zhu Chen; Yue-Ying Wang; Saijuan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

9.  Human TRIM gene expression in response to interferons.

Authors:  Laetitia Carthagena; Anna Bergamaschi; Joseph M Luna; Annie David; Pradeep D Uchil; Florence Margottin-Goguet; Walther Mothes; Uriel Hazan; Catherine Transy; Gianfranco Pancino; Sébastien Nisole
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

Review 10.  Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways.

Authors:  Umar-Faruq Cajee; Rodney Hull; Monde Ntwasa
Journal:  Int J Mol Sci       Date:  2012-09-19       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.